AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32282335 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-drinking patients with NAFLD
Number of subjects: 7079
Study 32282545 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 176
Study 32282545 — intervention group
Group type: EXPERIMENTAL
Intervention: Good adherence to repeated FMT
Number of subjects: 176
Study 32282545 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory preparation process
Number of subjects: 176
Study 32282545 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial Mayo score at 1-month post-FMT
Number of subjects: 176
Study 32282545 — intervention group
Group type: EXPERIMENTAL
Intervention: FMT
Number of subjects: 176
Study 32282612 — intervention group
Group type: EXPERIMENTAL
Intervention: First 1,000 Days program (intervention); includes enhanced gestational weight gain tracking and counseling, screening for adverse health behaviors, patient navigation, educational materials, and individualized health coaching.
Number of subjects: 1571
Study 32282612 — intervention group
Group type: EXPERIMENTAL
Intervention: First 1,000 Days program (intervention); among women who were overweight at the start of pregnancy.
Number of subjects: 1571
Study 32282612 — intervention group
Group type: EXPERIMENTAL
Intervention: First 1,000 Days program (intervention); among women with prepregnancy BMIs of 30 or higher.
Number of subjects: 1571
Study 32282661 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicolor confocal scanning laser ophthalmoscopy (cSLO)
Number of subjects: 30
Study 32282661 — intervention group
Group type: COMPARATOR
Intervention: Swept source optical coherence tomography (as reference)
Number of subjects: 30
Study 32282808 — intervention group
Group type: EXPERIMENTAL
Intervention: targeted provider-initiated testing and counselling (tPITC)
Number of subjects: 1990
Study 32283280 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported evaluation of sleep on a 0-10 numerical scale (PSAID-12)
Number of subjects: 396
Study 32283280 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported levels of anxiety
Number of subjects: 396
Study 32283280 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported levels of pain
Number of subjects: 396
Study 32283280 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflammation
Number of subjects: 396
Study 32283326 — intervention group
Group type: EXPERIMENTAL
Intervention: NIR-ICG imaging after conservative ureteral procedures
Number of subjects: 31
Study 32283645 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic multi-strain formulation
Number of subjects: 0
Study 32283645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32284075 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0
Study 32284274 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY-TT
Number of subjects: 184
Study 32284274 — intervention group
Group type: COMPARATOR
Intervention: MenC-CRM
Number of subjects: 184
Study 32284384 — intervention group
Group type: EXPERIMENTAL
Intervention: Gepotidacin (GSK2140944), dosage and duration not specified
Number of subjects: 0
Study 32284391 — intervention group
Group type: EXPERIMENTAL
Intervention: EarlySense device
Number of subjects: 500
Study 32284391 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibel device
Number of subjects: 500
Study 32284391 — intervention group
Group type: EXPERIMENTAL
Intervention: Verification and accuracy evaluation phase
Number of subjects: 500
Study 32284391 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical feasibility evaluation phase
Number of subjects: 500
Study 32284874 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod (high exposure, ≥8 years)
Number of subjects: 175
Study 32284874 — intervention group
Group type: COMPARATOR
Intervention: Fingolimod (low exposure, <8 years)
Number of subjects: 175
Study 32284945 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity modification and knee-strengthening exercises
Number of subjects: 51
Study 32285088 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful yoga intervention (1 hour, thrice weekly for 3 months)
Number of subjects: 31
Study 32285088 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 31
Study 32285107 — intervention group
Group type: EXPERIMENTAL
Intervention: McKeown oesophagectomy
Number of subjects: 1540
Study 32285107 — intervention group
Group type: COMPARATOR
Intervention: Ivor Lewis oesophagectomy
Number of subjects: 1540
Study 32285130 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Low Back Pain Disability Questionnaire (MDQ)
Number of subjects: 182276
Study 32285130 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck Disability Index (NDI)
Number of subjects: 182276
Study 32285143 — intervention group
Group type: EXPERIMENTAL
Intervention: GAP (Glasgow Coma Scale, Age and Pressure)
Number of subjects: 2112
Study 32285143 — intervention group
Group type: EXPERIMENTAL
Intervention: MGAP (mechanism + GAP)
Number of subjects: 2112
Study 32285143 — intervention group
Group type: EXPERIMENTAL
Intervention: RISC2
Number of subjects: 2112
Study 32285143 — intervention group
Group type: EXPERIMENTAL
Intervention: (M)GAP scores
Number of subjects: 2112
Study 32285143 — intervention group
Group type: EXPERIMENTAL
Intervention: GAP
Number of subjects: 2112
Study 32285251 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea (OSA) group
Number of subjects: 62
Study 32285251 — intervention group
Group type: COMPARATOR
Intervention: No obstructive sleep apnea (no-OSA) group
Number of subjects: 62
Study 32285251 — intervention group
Group type: EXPERIMENTAL
Intervention: Both OSA and no-OSA groups
Number of subjects: 62
Study 32285318 — intervention group
Group type: EXPERIMENTAL
Intervention: Random forest full model
Number of subjects: 3469
Study 32285318 — intervention group
Group type: EXPERIMENTAL
Intervention: Random forest reduced model
Number of subjects: 3469
Study 32285318 — intervention group
Group type: COMPARATOR
Intervention: Mehran risk score model
Number of subjects: 3469
Study 32285998 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA) at 15 mg/kg/day during radiation therapy and continued post-radiation, followed by bevacizumab at 10 mg/kg biweekly after radiation.
Number of subjects: 38
Study 32285998 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA) and bevacizumab after radiation therapy.
Number of subjects: 38
Study 32286195 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose CT screening for lung cancer using Lung-RADS categories 3 or 4.
Number of subjects: 0
Study 32286195 — intervention group
Group type: COMPARATOR
Intervention: Lung-RADS diagnostic performance in predicting lung cancer.
Number of subjects: 0
Study 32286862 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma aldosterone levels
Number of subjects: 0
Study 32286862 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial mitochondrial functions
Number of subjects: 0
Study 32286905 — intervention group
Group type: EXPERIMENTAL
Intervention: CD22-targeted CAR T cells
Number of subjects: 58
Study 32287122 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine-learning algorithm (SVM) using RIP sensor
Number of subjects: 26
Study 32287122 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine-learning algorithm (SVM) using intranasal pressure sensor
Number of subjects: 26
Study 32287122 — intervention group
Group type: COMPARATOR
Intervention: Domain experts
Number of subjects: 26
Study 32287128 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning model trained on sleep EEG data using dexmedetomidine as a prototype drug
Number of subjects: 30
Study 32287129 — intervention group
Group type: EXPERIMENTAL
Intervention: optical blood pressure monitoring (oBPM)
Number of subjects: 40
Study 32289043 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory-confirmed influenza diagnosis
Number of subjects: 501
Study 32289043 — intervention group
Group type: EXPERIMENTAL
Intervention: Other respiratory viruses
Number of subjects: 501
Study 32289043 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-infection with influenza and other respiratory viruses
Number of subjects: 501
Study 32289043 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza virus types
Number of subjects: 501
Study 32289043 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct medical costs associated with laboratory-confirmed influenza
Number of subjects: 501
Study 32289161 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuminuria (ACR ≥30 mg/g) for ≥2 annual measurements classified as persistent albuminuria (PA).
Number of subjects: 303
Study 32289161 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuminuria progression with age.
Number of subjects: 303
Study 32289161 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent albuminuria (PA).
Number of subjects: 303
Study 32289161 — intervention group
Group type: COMPARATOR
Intervention: Participants with PA compared to those without PA.
Number of subjects: 303
Study 32289161 — intervention group
Group type: COMPARATOR
Intervention: Adults with albuminuria compared to those without albuminuria.
Number of subjects: 303
Study 32289205 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh embryo transfer IVF
Number of subjects: 902891
Study 32289205 — intervention group
Group type: COMPARATOR
Intervention: Frozen-thawed embryo transfer IVF
Number of subjects: 902891
Study 32289205 — intervention group
Group type: COMPARATOR
Intervention: Natural conception
Number of subjects: 902891
Study 32289718 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-pulse TMS
Number of subjects: 2
Study 32290822 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention aimed at improving personal and environmental hygiene among primary school children.
Number of subjects: 0
Study 32290822 — intervention group
Group type: COMPARATOR
Intervention: Pre-intervention phase survey and qualitative exploration.
Number of subjects: 0
Study 32290822 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-intervention assessment using paired t-test.
Number of subjects: 0
Study 32290833 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiplex PCR (mPCR) for detection of antimicrobial resistance
Number of subjects: 94
Study 32290838 — intervention group
Group type: EXPERIMENTAL
Intervention: Triptorelin SR (11.25 mg) plus Tibolone (2.5 mg)
Number of subjects: 27
Study 32291090 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgically corrected VSD patients
Number of subjects: 120
Study 32291090 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with small, unrepaired VSD
Number of subjects: 120
Study 32291090 — intervention group
Group type: COMPARATOR
Intervention: Healthy age- and gender-matched controls
Number of subjects: 120
Study 32291269 — intervention group
Group type: EXPERIMENTAL
Intervention: Tin protoporphyrin (SnPP)
Number of subjects: 0
Study 32291269 — intervention group
Group type: EXPERIMENTAL
Intervention: SnPP
Number of subjects: 0
Study 32291308 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC) for 1 hour
Number of subjects: 27
Study 32291308 — intervention group
Group type: COMPARATOR
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 27
Study 32291564 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood cancer survivors
Number of subjects: 472
Study 32291564 — intervention group
Group type: COMPARATOR
Intervention: IFPS II controls
Number of subjects: 472
Study 32291773 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-derived muscle thickness at mid-upper arm and bilateral thighs, including age, sex, and the Charlson Comorbidity Index.
Number of subjects: 50
Study 32291773 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-derived muscle thickness at each landmark.
Number of subjects: 50
Study 32291773 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound prediction models.
Number of subjects: 50
Study 32291833 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender minority students (transgender, genderqueer/non-binary)
Number of subjects: 41412
Study 32291833 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual minority subgroups (pansexual, bisexual, queer, mostly gay/lesbian)
Number of subjects: 41412
Study 32291833 — intervention group
Group type: EXPERIMENTAL
Intervention: Pansexual students
Number of subjects: 41412
Study 32291833 — intervention group
Group type: COMPARATOR
Intervention: Cisgender peers
Number of subjects: 41412
Study 32291833 — intervention group
Group type: COMPARATOR
Intervention: Heterosexuals
Number of subjects: 41412
Study 32293279 — intervention group
Group type: EXPERIMENTAL
Intervention: In-office insertion of the BioMonitor 2
Number of subjects: 82
Study 32293300 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma levels of IL-17 and IL-23 at 2 or 7 days post ROSC
Number of subjects: 21
Study 32293300 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma levels of IL-17 and IL-23
Number of subjects: 21
Study 32293300 — intervention group
Group type: COMPARATOR
Intervention: Plasma creatinine levels, AST and ALT levels
Number of subjects: 21
Study 32293300 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma levels of IL-17, IL-22, IL-23 and IL-33
Number of subjects: 21
Study 32293348 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal and perinatal conditions, genetic and epigenetic factors, immunophenotyping, evaluation of allergy biomarkers in cord blood.
Number of subjects: 250
Study 32293348 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal conditions and epigenetic modifications.
Number of subjects: 250
Study 32293348 — intervention group
Group type: EXPERIMENTAL
Intervention: Composition/diversity of maternal gut, placenta, breastmilk, and infant gut microbiome.
Number of subjects: 250
Study 32293348 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental exposures (perinatal outdoor and indoor pollution, allergens, and endotoxin).
Number of subjects: 250
Study 32293449 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP > 88.64 pg/mL
Number of subjects: 54
Study 32293449 — intervention group
Group type: COMPARATOR
Intervention: NT-proBNP ≤ 88.64 pg/mL
Number of subjects: 54
Study 32293471 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein supplementation
Number of subjects: 58
Study 32293471 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric carbohydrate beverage
Number of subjects: 58
Study 32293471 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 58
Study 32293504 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal dietary habits/physical activity (T1-T3)
Number of subjects: 60
Study 32293504 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth mode (cesarean section vs. vaginal delivery)
Number of subjects: 60
Study 32293504 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal pre-pregnancy BMI (BMI < 25 Kg/m)
Number of subjects: 60
Study 32293506 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP set at 15 or 20 cmH2O
Number of subjects: 12
Study 32293568 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated smartphone-based financial incentives for smoking cessation (up to US $250 over 12 weeks)
Number of subjects: 16
Study 32293568 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated smartphone-based financial incentives for smoking cessation
Number of subjects: 16
Study 32293574 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat self-monitoring
Number of subjects: 258
Study 32293574 — intervention group
Group type: COMPARATOR
Intervention: Traditional monitoring
Number of subjects: 258
Study 32293641 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab
Number of subjects: 12
Study 32293940 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 32294529 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoscore Low (IS Low)
Number of subjects: 1322
Study 32294529 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoscore Intermediate + High (IS Int + High)
Number of subjects: 1322
Study 32294529 — intervention group
Group type: EXPERIMENTAL
Intervention: mFOLFOX6 (6 months)
Number of subjects: 1322
Study 32294529 — intervention group
Group type: COMPARATOR
Intervention: mFOLFOX6 (3 months)
Number of subjects: 1322
Study 32294561 — intervention group
Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA (400-800U)
Number of subjects: 132
Study 32294561 — intervention group
Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA treatment for pes equinovarus
Number of subjects: 132
Study 32294561 — intervention group
Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA treatment
Number of subjects: 132
Study 32295400 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraine patients with ictal neck pain
Number of subjects: 100
Study 32295400 — intervention group
Group type: COMPARATOR
Intervention: Migraine patients without ictal neck pain
Number of subjects: 100
Study 32295400 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 100
Study 32295455 — intervention group
Group type: EXPERIMENTAL
Intervention: Nellix Endoprosthesis
Number of subjects: 0
Study 32295504 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous recombinant tissue-type plasminogen activator
Number of subjects: 272
Study 32295504 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy
Number of subjects: 272
Study 32295504 — intervention group
Group type: COMPARATOR
Intervention: Overall population
Number of subjects: 272
Study 32295504 — intervention group
Group type: EXPERIMENTAL
Intervention: Age <75 years
Number of subjects: 272
Study 32295504 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial NIHSS score 0 to 3
Number of subjects: 272
Study 32295504 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood glucose level ≤140 mg/dL
Number of subjects: 272
Study 32295510 — intervention group
Group type: EXPERIMENTAL
Intervention: Onboard computed tomography angiography (CTA) with direct ET team notification
Number of subjects: 0
Study 32295510 — intervention group
Group type: COMPARATOR
Intervention: No onboard CTA (historical control group)
Number of subjects: 0
Study 32295510 — intervention group
Group type: EXPERIMENTAL
Intervention: Onboard CTA
Number of subjects: 0
Study 32295774 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with chronic conditions
Number of subjects: 0
Study 32295774 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (HC)
Number of subjects: 0
Study 32295829 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin calcium (4 mg/day) for 180 days
Number of subjects: 12
Study 32296355 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone ER
Number of subjects: 120
Study 32296355 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 120
Study 32296711 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation, dosage not specified, duration not specified
Number of subjects: 0
Study 32296711 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32296873 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivosidenib 500-mg QD
Number of subjects: 0
Study 32296873 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivosidenib
Number of subjects: 0
Study 32296969 — intervention group
Group type: EXPERIMENTAL
Intervention: Global longitudinal strain (GLS) by cardiac magnetic resonance feature tracking (CMR-FT)
Number of subjects: 232
Study 32296969 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of GLS to a baseline model comprising LVEF, infarct size, and microvascular obstruction
Number of subjects: 232
Study 32297284 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirfenidone
Number of subjects: 219
Study 32297876 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural garment (Posture Plus Force) worn for 2 to 4 hours per day for 90 days
Number of subjects: 32
Study 32297876 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy sessions (5 sessions of 20 minutes each) for stretching and strengthening exercises, continued at home for 90 days
Number of subjects: 32
Study 32297945 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment Expectation
Number of subjects: 0
Study 32297945 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32298144 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with large hrQoL improvement (≥18 points increase in Atrial Fibrillation Effect on Quality-of-Life score)
Number of subjects: 636
Study 32298144 — intervention group
Group type: COMPARATOR
Intervention: Patients without large hrQoL improvement
Number of subjects: 636
Study 32298288 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined neoadjuvant chemotherapy with bevacizumab
Number of subjects: 0
Study 32298288 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 32298429 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttreatment bone marrow biopsy (BMB) histology
Number of subjects: 0
Study 32298429 — intervention group
Group type: EXPERIMENTAL
Intervention: Postinduction BMB histology
Number of subjects: 0
Study 32298429 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow evaluation
Number of subjects: 0
Study 32298699 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone treatment
Number of subjects: 66
Study 32298699 — intervention group
Group type: EXPERIMENTAL
Intervention: Sputum microbiota
Number of subjects: 66
Study 32298699 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral microbiota
Number of subjects: 66
Study 32298699 — intervention group
Group type: EXPERIMENTAL
Intervention: Sputum and oral microbiota
Number of subjects: 66
Study 32298906 — intervention group
Group type: EXPERIMENTAL
Intervention: High RT dose to the left hippocampus
Number of subjects: 78
Study 32298906 — intervention group
Group type: EXPERIMENTAL
Intervention: RT dose to the left hippocampus, left temporal lobe, left frontal lobe, and total frontal lobe
Number of subjects: 78
Study 32298906 — intervention group
Group type: EXPERIMENTAL
Intervention: RT dose to the thalamus and the left frontal lobe
Number of subjects: 78
Study 32298906 — intervention group
Group type: EXPERIMENTAL
Intervention: RT dose to the brain and thalamus
Number of subjects: 78
Study 32298961 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictograph illustrating uncertainty for local recurrence risks with textual explanation
Number of subjects: 100
Study 32298961 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal labels for prevalence and severity of side-effects
Number of subjects: 100
Study 32299118 — intervention group
Group type: EXPERIMENTAL
Intervention: INVADE intervention program
Number of subjects: 10663